-
Hi, thanks for the opportunity. Umang, you just mentioned about a certain program concentration. If you could share the program and customer concentration in revenue for each of the three segments. The second would be any specific examples of AI implementation that you are seeing which is enabling you either to get better quality output or get output faster, especially in the later stages of your programs.
Read in transcript -
Could you share your customer concentration for the CDMO segment by program or molecule and by customer? So, what is the revenue salience of top one, top three, and top five molecules? Yann D’Herve: We do not give this level of details. Nevertheless, I can answer some of the question on customer concentration, right? And you can see that in our results, right?
Read in transcript
Analyst questions
Siddharth Negandhi
CWC
1Call
1Company
COHANCE
All company callsCohance Lifesciences Limited
Cohance Lifesciences Limited CC-May26.pdf
12 May 2026